Gardasil 9 syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F98XR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,679
Award facts
- Contract value 100% obligated
- $11,678.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $11,678.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GARDASIL 9 vaccine in 0.5ML syringes on January 23, 2026, with an ultimate completion date of January 26, 2026. This is a non-set-aside, competitively awarded contract for delivery to the company's headquarters location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 vehicle running through December 31, 2031, which serves as the primary procurement mechanism for pharmaceutical products and medical supplies supporting military healthcare programs globally.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor in the federal supply chain, particularly for the Defense Health Agency and military treatment facilities. The company's portfolio includes a comprehensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This specific delivery order for GARDASIL 9 vaccine aligns with the DLA's ongoing pharmaceutical procurement needs to support military healthcare operations, demonstrating the vendor's continued capability to fulfill time-sensitive federal medical supply requirements on a competitive basis.
Quick answers
Who was awarded contract SPE2DR26F98XR?
SPE2DR26F98XR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F98XR worth?
The government has obligated $11,679 on SPE2DR26F98XR.
Is contract SPE2DR26F98XR an order under another contract?
Yes. SPE2DR26F98XR is a delivery order under SPE2DR25D7060, an indefinite delivery contract.
Was contract SPE2DR26F98XR competed?
The extent of competition for SPE2DR26F98XR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award